Locations
United States · Greenville, SC, USA · North America · United States Minor Outlying Islands
industry
Biotechnology
Size
11 - 50 employees
Stage
Other
founded in
2005
KIYATEC utilizes the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies. Its 3DKUBE technology platform conveniently and cost-effectively incorporates perfusion flow, accommodates all scaffold materials, allows in situ imaging, models complex human biology using segregated cell co-culture, and is a single-use disposable. 3DKUBE cell-based assays leverage these features to create better in vitro prediction of complex biochemical responses in humans, with a focus on the evaluation of drug toxicity and efficacy prior to use in human clinical trials.
Something looks off?